Mutational landscape of AKT1/2/3 in Chinese patients with solid tumors.

e15566Background: As a central component of PI3K/AKT pathway, AKT serves as an attractive target of anti-cancer strategy with various AKT inhibitors, which show great promise in phase I/II clinical...